Market Place
Sourcing Support
Stock Under Active Eyes: ContraVir Pharmaceuticals, Inc. (CTRV)
25 Jul 2018 //
BITCOINPRICE
ContraVir has ‘near-term catalysts’ that should drive ‘higher valuation,’
23 Jul 2018 //
PROACTIVEINVESTORS
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
23 Jul 2018 //
PRESS RELEASE
ContraVir CEO excited to get hepatitis B drug to patients in new study
09 Jul 2018 //
PROACTIVEINVESTORS
ContraVir Pharmaceuticals to Present at Virtual Investor Conference
05 Jul 2018 //
PR NEWSWIRE
ContraVir Announces $10.8 M in Expected Gross Proceeds from Recently Expired
29 Jun 2018 //
PRESS RELEASE
ContraVir Announces the Approval of the IND & Initiation CRV431 in the US
14 Jun 2018 //
PRESS RELEASE
ContraVir`s Cyclophilin Inhib, CRV431, Reduces Dev & Progression Liver Tumors
30 May 2018 //
PRESS RELEASE
ContraVir to Present Three Posters at the 53rd Annual Liver Congress™
30 Apr 2018 //
PRESS RELEASE
ContraVir`s Announces TXL™ Has Been Granted Orphan Drug Designation
22 Feb 2018 //
PRESS RELEASE
Contravir Pharmaceuticals Reaches Agreement FDA , NDA Package
12 Feb 2018 //
PRESS RELEASE
ContraVir to Receive Non-Dilutive Funding through New Jersey Technology (NOL)
06 Nov 2017 //
PRESS RELEASE
ContraVir Receives HBV IND Approval for Tenofovir Exalidex (TXL™) in the US
11 Sep 2017 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.